IIM
Ipswich Investment Management Portfolio holdings
AUM
$414M
This Quarter Return
+0.42%
1 Year Return
+15.04%
3 Year Return
+70.41%
5 Year Return
+132.95%
10 Year Return
+315.52%
AUM
$237M
AUM Growth
+$237M
(+0.35%)
Cap. Flow
+$3.01M
Cap. Flow
% of AUM
1.27%
Top 10 Holdings %
Top 10 Hldgs %
28.75%
Holding
156
New
6
Increased
56
Reduced
50
Closed
5
Top Buys
| 1 |
Diageo
DEO
|
$2.59M |
| 2 |
Accenture
ACN
|
$2.32M |
| 3 |
CRISPR Therapeutics
CRSP
|
$403K |
| 4 |
Danaher
DHR
|
$251K |
| 5 |
Cognizant
CTSH
|
$221K |
Top Sells
| 1 |
Schlumberger
SLB
|
$1.42M |
| 2 |
Caterpillar
CAT
|
$868K |
| 3 |
POT
Potash Corp Of Saskatchewan
POT
|
$344K |
| 4 |
Amazon
AMZN
|
$340K |
| 5 |
National Fuel Gas
NFG
|
$280K |
Sector Composition
| 1 | Healthcare | 17.42% |
| 2 | Technology | 16.77% |
| 3 | Energy | 12.57% |
| 4 | Financials | 12.45% |
| 5 | Industrials | 11.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Scotiabank
BNS
$78.1B
| $2.88M | 1.21% |
46,641
+2,420
| +5% | +$149K |
|
27
Merck
MRK
$210B
| $2.63M | 1.11% |
50,636
+188
| +0.4% | +$9.77K |
|
|
28
CRISPR Therapeutics
CRSP
$4.82B
| $2.61M | 1.1% |
57,075
+8,818
| +18% | +$403K |
|
|
29
Diageo
DEO
$61.1B
| $2.59M | 1.09% |
+19,118
| New | +$2.59M |
|
30
Procter & Gamble
PG
$370B
| $2.54M | 1.07% |
32,074
+995
| +3% | +$78.9K |
|
31
Marsh & McLennan
MMC
$101B
| $2.41M | 1.02% |
29,155
+1,620
| +6% | +$134K |
|
32
Labcorp
LH
$22.8B
| $2.39M | 1.01% |
17,195
+210
| +1% | +$29.2K |
|
33
Church & Dwight Co
CHD
$22.7B
| $2.38M | 1% |
47,200
+684
| +1% | +$34.4K |
|
|
34
Accenture
ACN
$158B
| $2.32M | 0.98% |
+15,090
| New | +$2.32M |
|
35
Truist Financial
TFC
$59.8B
| $2.3M | 0.97% |
44,266
+506
| +1% | +$26.3K |
|
36
Oracle
ORCL
$628B
| $2.22M | 0.94% |
48,512
-560
| -1% | -$25.6K |
|
|
PX
37
DELISTED
Praxair Inc
PX
| $2.19M | 0.93% |
15,198
+60
| +0.4% | +$8.66K |
|
38
Colgate-Palmolive
CL
$67.7B
| $2.16M | 0.91% |
30,081
-139
| -0.5% | -$9.96K |
|
39
Duke Energy
DUK
$94.5B
| $2.12M | 0.89% |
27,319
+515
| +2% | +$39.9K |
|
40
PepsiCo
PEP
$203B
| $2.03M | 0.86% |
18,602
-50
| -0.3% | -$5.46K |
|
41
Novartis
NVS
$248B
| $1.93M | 0.81% |
26,594
+1,609
| +6% | +$117K |
|
42
Bristol-Myers Squibb
BMY
$96.7B
| $1.88M | 0.79% |
29,667
+1,050
| +4% | +$66.4K |
|
43
AT&T
T
$208B
| $1.7M | 0.72% |
63,228
+1,305
| +2% | +$35.1K |
|
44
Thermo Fisher Scientific
TMO
$183B
| $1.64M | 0.69% |
7,932
-58
| -0.7% | -$12K |
|
45
Biogen
BIIB
$20.8B
| $1.63M | 0.69% |
5,951
+15
| +0.3% | +$4.11K |
|
46
Royal Caribbean
RCL
$96.4B
| $1.58M | 0.67% |
13,454
-440
| -3% | -$51.8K |
|
47
Akamai
AKAM
$11.1B
| $1.58M | 0.67% |
22,302
+278
| +1% | +$19.7K |
|
48
Coca-Cola
KO
$297B
| $1.57M | 0.66% |
36,065
+740
| +2% | +$32.1K |
|
49
McDonald's
MCD
$226B
| $1.56M | 0.66% |
9,982
-1,451
| -13% | -$227K |
|
50
TotalEnergies
TTE
$135B
| $1.45M | 0.61% |
25,174
| – | – |
|